Brief: LG AI Research Signs Master Agreement With D&D Pharmatech For Oral Peptide Drug Development
17/06/2026 15:05
BRIEF-LG AI Research Signs Master Agreement With D&D Pharmatech For Oral Peptide Drug Development June 17 (Reuters) - LG AI Research:
LG AI RESEARCH ANNOUNCES COLLABORATION WITH D&D PHARMATECH TO ACCELERATE NEXT-GENERATION ORAL PEPTIDE DRUG DISCOVERY
LG AI RESEARCH - SIGNS MASTER AGREEMENT WITH D&D PHARMATECH FOR ORAL PEPTIDE DRUG DEVELOPMENT
Source text: ID:nPn6ljC71a
Further company coverage: 003550.KS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on LG
See all newsBrief: LG AI Research Signs Master Agreement With D&D Pharmatech For Oral Peptide Drug Development
Nvidia CEO says company is working with LG on humanoid robots and data centers
Nvidia, SK to detail cooperation plan as Huang flags prolonged chip shortage (updated)
Nvidia CEO, SK chairman to announce cooperation plan on Monday - report
Nvidia CEO says robotics is South Korea's next big sector, points to 'some surprises' (updated)